News

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...
Former University of Hawaii football teammates and coaches are rooting for Brent Rausch’s recovery from an intestinal problem ...
If you would like to provide news about a coming event, just email harleytom20@gmail.com with the information and we will get ...
Deone Walker, to me – when you turn on the tape, he does things at his size that you’re not expecting someone at that size to ...
At the diabetes conference, Eli Lilly presented results of a phase 1 trial of its experimental drug, eloralintide. Unlike GLP ...
A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase ...
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
Trial finds weight loss drug taken monthly helps people lose 20% of body weight – but adverse GI events were ‘common’ - The ...
Biotech Metsera posts weight loss data for amylin analog, teeing up monthly GLP-1 combo plans By Nick Paul Taylor Jun 9, 2025 7:00am Metsera obesity drugs Clinical Data GLP-1 ...
What seems to be getting the most attention lately, however, are the number of people who have lost weight with certain medications. And the most popular ones are not pills. They are injections.
Shilpa Shetty avoids eating carbs after 7 PM to stay fit. A weight loss coach explains how this one habit alone can help you lose 3–4 kg in just a month.  ...
What’s interesting is that this drug is NOT approved by the Food and Drug Administration as a treatment for weight loss. It is approved for the treatment of Type 2 diabetes in adults.